Spongocytidine hydrochloride

Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)

Molecular Formula: C₉H₁₄ClN₃O₅

InChI: InChI=1/C9H13N3O5.ClH/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8;/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16);1H/t4-,6-,7+,8-;/m1./s1/f/h10H2;

InChIKey: InChIKey=KCURWTAZOZXKSJ-ZPEWDUCLDA
SMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl

Names:
    Alexan hydrochloride
    Arabitin hydrochloride
    Aracytidine hydrochloride
    Aracytin hydrochloride
    Ara-C hydrochloride
    Cylocide
    CYTARABINE HYDROCHLORIDE
    Cytosar hydrochloride
    Iretin
    Spongocytidine hydrochloride
    4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one hydrochloride

Registries:
    PubChem CID 6252
    PubChem ID 149175